Perspective Therapeutics to Participate in Key Healthcare Investor Conferences in December 2024
Perspective Therapeutics will present at the Piper Healthcare Conference and Evercore HealthCONx, sharing updates on radiopharmaceutical advancements.
SEATTLE, Nov. 27, 2024 Perspective Therapeutics, Inc., a leading radiopharmaceutical company focused on innovative cancer treatment solutions, announced its participation in two major healthcare investor conferences in early December 2024. The company's senior leadership team will engage with investors and industry stakeholders through fireside chats and one-on-one meetings.
On December 3, 2024, Perspective Therapeutics will attend the 36th Annual Piper Healthcare Conference in New York, NY. The fireside chat, scheduled from 10:00 to 10:25 AM ET, will provide an overview of the company’s recent advancements in radiopharmaceutical applications and strategic growth initiatives.
Following this, the company will participate in the 7th Annual Evercore HealthCONx on December 5, 2024, in Coral Gables, FL. The fireside chat at this event is set for 10:50 to 11:10 AM ET, offering another opportunity for investors to gain insights into the company’s ongoing projects and future outlook. These engagements reflect Perspective Therapeutics' commitment to enhancing shareholder value and driving innovation in cancer care.
My international experience as a researcher in Taiwan for three years has equipped me with a global perspective, enabling me to create content that resonates with an international audience.
More from Pharma News
All stories →
Bristol-Myers Squibb Gains FDA Accelerated Approval for Iberdomide in Relapsed or Refractory Multiple Myeloma
Eton Pharmaceuticals Gains FDA Fast Track for AMGLIDIA and Targets 2027 NDA with ASN-001 Acquisition
Discussion